Joint Formulary & PAD

Tocilizumab - Rheumatoid arthritis

You are here : Home > Formulary Search > Tocilizumab - Rheumatoid arthritis

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Intravenous infusion
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
Guidelines
ICB
NICE
SPC
Restrictions / Comments :

Documentation

NICE Technology Appraisal
NICE TA375 - Biologics in Rheumatoid Arthritis - January 2016
NICE Technology Appraisal
NICE TA247 - Tocilizumab for the treatment of rheumatoid arthritis - February 2012

PAD Profile

ChemicalSubstance :
Tocilizumab
Indication :
Rheumatoid arthritis
Group Name :
Keywords :
RA, Biologic, NICE, immunosuppressant, Interleukin-6 inhibitor, DMARD, bDmard, Disease modulating, Rheumatology, cytokine modulator
Brand Names Include :
RoActemra, Tyenne
Important Information :
Severe disease only
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Rheumatoid arthritis
Supporting Documents :
2

Committee Recommendations (0)

  • No records returned.

Other Indications

Below are listed other indications that Tocilizumab is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Rheumatoid arthritis.